Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares changing hands. The stock had previously closed at $0.31.
Sino Biopharmaceutical Stock Performance
The business has a 50-day moving average price of $0.36 and a 200 day moving average price of $0.39.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- Compound Interest and Why It Matters When Investing
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Basic Materials Stocks Investing
- Generac Powers Ahead on the Electrification Mega-Trend
- Trading Halts Explained
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.